Tatiana Helfenstein

Tatiana Helfenstein

Auto-generated profile, based on publicly available information

Tatiana Helfenstein

Cardiology Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2011 in International Journal of Experimental Pathology
Verified
Journal Article
Closed access
PDF file
THTatiana Helfenstein
Tatiana Helfenstein
FFFrancisco A. Fonseca
Francisco A. Fonseca
SISílvia S. Ihara
Sílvia S. Ihara
JBJuliana M. Bottós
Juliana M. Bottós
FMFlávio T. Moreira
Flávio T. Moreira
Maria Cristina IzarMaria Cristina Izar
Maria Cristina Izar

2 August 2011 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
SRSilvia C Ramos
Silvia C Ramos
FFFrancisco Antonio Antonio Helfenstein Helfenstein Fonseca
Francisco Antonio Antonio Helfenstein Helfenstein Fonseca
SKSoraia H Kasmas
Soraia H Kasmas
FMFlávio T Moreira
Flávio T Moreira
THTatiana Helfenstein
Tatiana Helfenstein
Maria Cristina IzarMaria Cristina Izar
Maria Cristina Izar
Background: It has been demonstrated that statins can increase intestinal sterol absorption. Augments in phytosterolemia seems related to cardiovascular disease. Objective: We examined the role of soluble fiber intake in endogenous cholesterol synthesis and in sterol absorption among subjects under highly effective lipid-lowering therapy. Design: In an open label, randomized, parallel-design study with blinded endpoints, subjects with primary hypercholesterolemia (n = 116) were assigned to receive during 12 weeks, a daily dose of 25 g of fiber (corresponding to 6 g of soluble fibers) plus rosuvastatin 40 mg (n = 28), rosuvastatin 40 mg alone (n = 30), sinvastatin 40 mg plus ezetimibe 10 mg plus 25 g of fiber (n = 28), or sinvastatin 40 mg plus ezetimibe 10 mg (n = 30) alone. Results: The four assigned therapies produced similar changes in total cholesterol, LDL-cholesterol, and triglycerides (p < 0.001 vs. baseline) and did not change HDL-cholesterol. Fiber intake decreased plasma campesterol (p < 0.001 vs. baseline), particularly among those patients receiving ezetimibe (p < 0.05 vs. other groups), and β-sitosterol (p = 0.03 vs. baseline), with a trend for lower levels in the group receiving fiber plus ezetimibe (p = 0.07). Treatment with rosuvastatin alone or combined with soluble fiber was associated with decreased levels of desmosterol (p = 0.003 vs. other groups). Compared to non-fiber supplemented individuals, those treated with fibers had weight loss (p = 0.04), reduced body mass index (p = 0.002) and blood glucose (p = 0.047). Conclusion: Among subjects treated with highly effective lipid-lowering therapy, the intake of 25 g of fibers added favorable effects, mainly by reducing phytosterolemia. Additional benefits include improvement in blood glucose and anthropometric parameters.

1 May 2005 in Clinica Chimica Acta
Verified
Journal Article
Closed access
THTatiana Helfenstein
Tatiana Helfenstein
FFFrancisco A.H. Fonseca
Francisco A.H. Fonseca
WRWaldir G.M. Relvas
Waldir G.M. Relvas
ASAndreza O. Santos
Andreza O. Santos
MDMaria L. Dabela
Maria L. Dabela
MIMaria C.O. Izar
Maria C.O. Izar

29 September 2008 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
Maria Cristina IzarMaria Cristina Izar
Maria Cristina Izar
THTatiana Helfenstein
Tatiana Helfenstein
SISilvia S. Ihara
Silvia S. Ihara
WRWaldir G. Relvas
Waldir G. Relvas
ASAndreza O. Santos
Andreza O. Santos
FFFrancisco Antonio Antonio Helfenstein Helfenstein Fonseca
Francisco Antonio Antonio Helfenstein Helfenstein Fonseca

1 March 2014 in Life Sciences
Verified
Journal Article
Closed access
FMFlavio Tocci Moreira
Flavio Tocci Moreira
SRSilvia Cristina Ramos
Silvia Cristina Ramos
AMAndrea Moreira Monteiro
Andrea Moreira Monteiro
THTatiana Helfenstein
Tatiana Helfenstein
MGMagnus Gidlund
Magnus Gidlund
FFFrancisco Antonio Antonio Helfenstein Helfenstein Fonseca
Francisco Antonio Antonio Helfenstein Helfenstein Fonseca

1 January 2010 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
PDF file
WRWaldir G M Relvas
Waldir G M Relvas
MIMaria C O Izar
Maria C O Izar
HSHelena R C Segreto
Helena R C Segreto
AGAdelmo J Giordani
Adelmo J Giordani
SISilvia S M Ihara
Silvia S M Ihara
FFFrancisco Antonio Antonio Helfenstein Helfenstein Fonseca
Francisco Antonio Antonio Helfenstein Helfenstein Fonseca
Aim: Based on evidence that ionizing radiation can ameliorate chronic and autoimmune diseases in patients and experimental animals, we investigated the effects of radiation on the induction and development of experimental atherogenesis. Methods: Male New Zealand rabbits were divided into 5 groups and given an atherogenic diet for 90 days. Peritoneal and thoracic areas (9 Gy) were irradiated on the 1st and 45th days for groups 1 and 2, the 45th day for groups 3 and 4, and not at all for group 5. Prior to irradiation, the peritoneal cavity of animals from groups 1 and 3 was washed with buffered saline. Cells collected by peritoneal washing were reinfused into the peritoneal cavity of the same animal after irradiation. Animals from groups 2 and 4 were intraperitoneally injected with saline as a control. Results: Despite similar lipid profiles among the experimental groups, the percentage of aortas covered by plaques was remarkably reduced (p<0.001) among animals submitted to irradiation (groups 2 and 4). These differences were completely abolished in irradiated animals reconstituted with their own peritoneal cells. Conclusions: These findings point to an important role of resident inflammatory peritoneal cells in experimental atherogenesis.